American Journal of Preventive Medicine最新文献

{"title":"Achieving Equitable Lung Cancer Screening Implementation in a Texas Safety Net Health System","authors":"Michael Pignone MD, MPH ,&nbsp;Patrick Chang MS ,&nbsp;Nicole Kluz MPH ,&nbsp;Brandon Altillo MD, MPH ,&nbsp;Andrea Fekete MD ,&nbsp;Amaris Martinez BA ,&nbsp;Rachel Medbery MD ,&nbsp;Yvonne Queralt MD ,&nbsp;Koonj Shah MD ,&nbsp;LaTasha Vanin LCSW","doi":"10.1016/j.amepre.2024.09.016","DOIUrl":"10.1016/j.amepre.2024.09.016","url":null,"abstract":"<div><h3>Introduction</h3><div>A lung cancer screening program using low dose CT (LDCT) in a Federally Qualified Health Center (FQHC) in Central Texas was developed and assessed for equitable implementation.</div></div><div><h3>Methods</h3><div>From 11/2020–8/2023, patients aged 55–77 years who currently smoked or quit within 15 years with ≥20 pack-years of exposure were identified through EHR query and mailed outreach, or through direct provider referrals. A bilingual social worker confirmed eligibility, provided telecare shared decision-making (SDM), coordinated screening, and offered smoking cessation. To assess equity, LDCT completion across demographics was compared, in 2023.</div></div><div><h3>Results</h3><div>A total of 6,486 patients were mailed outreach materials; 479 patients responded, of whom 108 (22.5%) were eligible and 71 (65.7%) participated in SDM. 629 eligible patients were referred internally; 579 (92.0%) completed SDM. Of the 650 patients who completed SDM, 636 (97.8%) agreed to screening. Mean age was 61.7 years; 38.1% were female. The population was diverse: 35.8% identified as Latino, 17.8% as African American, 26.8% had Medicare or Medicaid, 48.0% used the county medical assistance program, 14.2% were uninsured, and 76.7% currently smoked. Overall, 528 (83.0%) patients completed LDCT. There were no statistically significant differences in completion by age, gender, race/ethnicity, or insurance status. Spanish-speaking patients were more likely to complete the CT than English speakers (OR 2.22, 95% CI=1.22, 4.41) and those who formerly smoked were more likely to complete the CT than patients who currently smoked (OR 1.93, 95% CI=1.12, 3.51).</div></div><div><h3>Conclusions</h3><div>The navigator-centered program achieved equitable implementation of lung cancer screening in a diverse FQHC system.</div></div>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":"68 2","pages":"Pages 227-235"},"PeriodicalIF":4.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142331830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Flavor and Device Choices Among People Who Use ENDS: Results From the PATH Study","authors":"Maansi Bansal-Travers PhD ,&nbsp;Cheryl Rivard MPH ,&nbsp;Cristine D. Delnevo PhD ,&nbsp;Amy Gross PhD ,&nbsp;Andrew Anesetti-Rothermel PhD ,&nbsp;Brittany Merson PhD ,&nbsp;Haijun Xiao MS ,&nbsp;Yu-Ching Cheng PhD ,&nbsp;MeLisa R. Creamer PhD ,&nbsp;Heather L. Kimmel PhD ,&nbsp;Cassandra A. Stanton PhD ,&nbsp;Eva Sharma PhD ,&nbsp;Kristie Taylor PhD ,&nbsp;Kristin Lauten MA ,&nbsp;Maciej Goniewicz PhD ,&nbsp;Andrew Hyland PhD","doi":"10.1016/j.amepre.2024.09.020","DOIUrl":"10.1016/j.amepre.2024.09.020","url":null,"abstract":"<div><h3>Introduction</h3><div>In guidance published in February 2020, the FDA described their intent to prioritize enforcement against the sale of flavored cartridge-based Electronic Nicotine Delivery Systems (ENDS) except tobacco and menthol flavors. This guidance was specific to cartridge-based ENDS and did not apply to other ENDS types or e-liquids sold in the U.S.. It remains unknown if use of certain types of ENDS devices and flavors changed following the publication of this guidance.</div></div><div><h3>Methods</h3><div>This analysis includes PATH Study data from Wave 5 (W5, 2018–2019) and Wave 6 (W6, 2021) and examines cross-sectional estimates of (1) use of flavored ENDS and (2) use of different device types. All analyses in this study were stratified by self-reported age (youth-aged 12–17 years at W5 and aged 14–17 years at W6, and adults-aged 18–20, 21–24, and 25+ years). Analyses were conducted in 2023–2024.</div></div><div><h3>Results</h3><div>Among adults aged 21 years and over, there were significant increases in the use of menthol or mint flavored ENDS. There were no substantial changes in flavors of ENDS used among youth or adults aged 18–20 years. Among all age groups, the use of cartridge-based ENDS was lower in 2021 than 2018–2019, with a notable shift to disposable-style ENDS.</div></div><div><h3>Conclusions</h3><div>Federal-level tobacco control actions taken in the U.S. in early 2020 prioritized enforcement against “any flavored, cartridge-based ENDS product (other than a tobacco- or menthol-flavored ENDS product).” Based on this analysis, there was a shift following the policy to menthol or mint-flavored ENDS and disposable-style ENDS.</div></div>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":"68 2","pages":"Pages 236-244"},"PeriodicalIF":4.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11757064/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142373476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Age Profiles of Suicide Attempt Among Sexual Minority Adolescents","authors":"Samuel J. Mann PhD ,&nbsp;Jamie L. Ryan PhD ,&nbsp;Harry Barbee PhD","doi":"10.1016/j.amepre.2024.10.021","DOIUrl":"10.1016/j.amepre.2024.10.021","url":null,"abstract":"","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":"68 2","pages":"Pages 412-414"},"PeriodicalIF":4.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142548761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Projected Impact of Replacing Juice With Whole Fruit in Early Care and Education","authors":"Daniel A. Zaltz PhD, MPH ,&nbsp;Brian W. Weir PhD, MHS, MPH ,&nbsp;Roni A. Neff PhD, ScM ,&nbsp;Sara E. Benjamin-Neelon PhD, JD, RD","doi":"10.1016/j.amepre.2024.10.017","DOIUrl":"10.1016/j.amepre.2024.10.017","url":null,"abstract":"<div><h3>Introduction</h3><div>The purpose of this study was to simulate potential changes in dietary intake and food costs by replacing juice with whole fruit among children ages 1–5 years attending U.S. early care and education settings between 2008 and 2020.</div></div><div><h3>Methods</h3><div>Estimated mean changes in daily intake of calories, sugar, fiber, calcium, vitamin C and overall food costs under plausible scenarios of replacing juice with whole fruit. Researchers fit hierarchical regression with children nested within early care and education nested within studies, adjusting for potential confounders.</div></div><div><h3>Results</h3><div>The sample consisted of 6,304 days of direct observation (90% aged 2 years or older, 51% female, 38% Black/African American) in 846 early care and education facilities (73% centers, 75% Child and Adult Care Food Program participants). Replacing juice with whole fruit would reduce energy intake by 8.2–27.3 kcal/day, reduce sugar by 3.4–5.6 g/d, increase fiber by 0.5–1.3 g/d, and have negligible impact on vitamin C and calcium. Replacing juice with whole fruit in early care and education would increase per-child daily food costs between $0.44 and 0.49, representing an increase from 3.8% for juice to approximately 9.8%–10.7% for whole fruit as a percent of total food costs.</div></div><div><h3>Conclusions</h3><div>Replacing juice with whole fruit in early care and education would result in increased fiber intake and decreased sugar and calories. A policy to replace juice with whole fruit in early care and education would likely cause an increased daily food cost and given the potential broad benefit of this dietary intervention, there may be reason to expand funding within nutrition assistance programs in early care and education.</div></div>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":"68 2","pages":"Pages 357-365"},"PeriodicalIF":4.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142548764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hypertensive Blood Pressure in Adolescent Females With Polycystic Ovary Syndrome","authors":"Sherry Zhang MD ,&nbsp;Jeanne A. Darbinian MPH ,&nbsp;Louise C. Greenspan MD ,&nbsp;Sahar Naderi MD ,&nbsp;Nirmala D. Ramalingam MPP ,&nbsp;Joan C. Lo MD","doi":"10.1016/j.amepre.2024.10.009","DOIUrl":"10.1016/j.amepre.2024.10.009","url":null,"abstract":"<div><h3>Introduction</h3><div>Polycystic ovary syndrome is associated with hypertension in women, but few population studies have examined findings among adolescents. This retrospective study examines PCOS and hypertensive blood pressure in a large adolescent population receiving routine healthcare.</div></div><div><h3>Methods</h3><div>Among females aged 13–17 years who had a well-child visit with systolic/diastolic blood pressure measured in a Northern California healthcare system (2013–2019), the outcome of hypertensive blood pressure (≥130/80 mmHg) was examined. Polycystic ovary syndrome was based on clinical diagnosis (ICD-9/10 256.4/E28.2) within 1 year of the visit. Overweight and obesity were defined by BMI 85th to &lt;95th percentile and ≥95th percentile, respectively; 1.7% with underweight (&lt;5th percentile) were excluded. Multivariable logistic regression was used to examine the association of polycystic ovary syndrome and hypertensive blood pressure, adjusting for age, race/ethnicity, BMI category, and estimated neighborhood deprivation index. Analyses were conducted in 2023–2024.</div></div><div><h3>Results</h3><div>The cohort included 224,418 females (mean age 14.9±1.4 years; 34.3% non-Hispanic White, 30.1% Hispanic, 19.5% Asian/Pacific Islander, and 9.7% Black). Overall, 18.7% had overweight and 15.8% had obesity. The prevalence of hypertensive blood pressure was 7.2%, much higher for those with polycystic ovary syndrome (18.2%) versus no polycystic ovary syndrome (7.1%, <em>p</em>&lt;0.001). In adjusted analyses, polycystic ovary syndrome was associated with 1.25-fold greater odds of hypertensive blood pressure (95% CI=1.10, 1.42). Similar findings were seen among the subset with obesity (OR=1.23 [95% CI=1.06, 1.42]).</div></div><div><h3>Conclusions</h3><div>Nearly 1 in 5 adolescents with polycystic ovary syndrome had hypertensive blood pressure. Polycystic ovary syndrome was associated with 25% increased adjusted odds of hypertensive blood pressure, emphasizing the importance of blood pressure surveillance in this population with higher cardiometabolic risk.</div></div>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":"68 2","pages":"Pages 408-411"},"PeriodicalIF":4.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142479933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Health Insurance and Self-Rated Health From Adolescence to Early Midlife in the U.S.","authors":"Xing Zhang PhD ,&nbsp;Tiffany L. Lemon PhD","doi":"10.1016/j.amepre.2024.10.002","DOIUrl":"10.1016/j.amepre.2024.10.002","url":null,"abstract":"<div><h3>Introduction</h3><div>Although health insurance is a critical tool for well-being across the life course, few studies have explored the long-term health implications of shifts in insurance coverage. This study examined whether changes in insurance types from adolescence to early midlife were associated with early midlife self-rated health.</div></div><div><h3>Methods</h3><div>This study used data from Wave I (1994–1995; average age 15.7 years), Wave IV (2008–2009; average age 28.7 years), and Wave V (2016–2018; average age 37.6 years) of Add Health, including 6,765 respondents from 1994 to 2018. Logistic regression was used to examine the association between health insurance status from adolescence to early midlife and early midlife self-rated health. The analyses were conducted from March to August 2024.</div></div><div><h3>Results</h3><div>Relative to having private insurance in adolescence and early midlife, the following health insurance statuses in adolescence and early midlife were significantly associated with poorer early midlife self-rated health: public in adolescence and early midlife (AOR=3.34; 95% CI=1.89, 5.91); uninsured in adolescence to public at early midlife (AOR=3.29; 95% CI=1.85, 5.85); private in adolescence to public at early midlife (AOR=3.36; 95% CI=2.46, 4.58), and private in adolescence to uninsured at early midlife (AOR=1.68; 95% CI=1.10, 2.55).</div></div><div><h3>Conclusions</h3><div>Health insurance statuses from adolescence to early midlife, specifically having or switching into public insurance, may be associated with poorer health in early midlife among individuals who were adolescents in the early 1990s. More research is needed to explore how insurance reform such as the Children's Health Insurance Program may have mitigated this association in future cohorts.</div></div>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":"68 2","pages":"Pages 257-263"},"PeriodicalIF":4.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinician Response to the 2021 USPSTF Recommendation for Colorectal Cancer Screening in Average Risk Adults Aged 45–49 Years","authors":"Joseph Carter Powers BA ,&nbsp;Michael B. Rothberg MD, MPH ,&nbsp;Jeffrey D. Kovach MS ,&nbsp;Nicholas J. Casacchia PharmD, MS ,&nbsp;Elizabeth Stanley MPH ,&nbsp;Kathryn A. Martinez PhD, MPH","doi":"10.1016/j.amepre.2024.10.003","DOIUrl":"10.1016/j.amepre.2024.10.003","url":null,"abstract":"<div><h3>Introduction</h3><div>In 2021, the USPSTF lowered the recommended age of colorectal cancer (CRC) screening initiation from 50 to 45 years. This study assessed clinician response to the updated guideline in a major health system.</div></div><div><h3>Methods</h3><div>This was a retrospective cohort study of average<strong>-</strong>risk, CRC screening–naïve adults aged 45–50 years with a primary care appointment between July 2018 and February 2023. The authors defined the pre–guideline change period as July 2018–February 2020 (pre-period) and the post–guideline change period as July 2021–February 2023 (post-period). Clinician ordering of any CRC screening type was assessed. Mixed effects Poisson regression was used to model the incidence rate ratio (IRR) of a patient receiving a screening order, including an interaction between age (45–49 years versus 50 years) and time period (pre- versus post-guideline change.) Variation in screening orders were also described by calendar quarter and clinician.</div></div><div><h3>Results</h3><div>There were 28,114 patients in the pre-period and 22,509 in the post-period. Compared to patients aged 40–49 years in the pre-period, those in the post-period were more likely to have screening ordered (IRR=12.1; 95% CI=11.3–13.0). The screening ordering rate increased for patients aged 50 years from the pre- to the post-period (IRR=1.08; 95% CI=1.01, 1.16) and was slightly higher than that of patients aged 45–49 years in the post-period (IRR=1.08; 95% CI=1.02, 1.14). All clinicians increased their ordering rate for patients aged 45–49 years. Within 5 months of the guideline change, the ordering rate for patients aged 45–49 years and 50 years was nearly the same.</div></div><div><h3>Conclusions</h3><div>Rapidly following the guideline change, clinicians increased their screening ordering rate for patients aged 45–49 years, indicating almost complete uptake of the recommendation.</div></div>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":"68 2","pages":"Pages 264-271"},"PeriodicalIF":4.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142479929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"ACPM Member Spotlight—Clarence Lam, MD, MPH, FACPM","authors":"","doi":"10.1016/j.amepre.2024.10.022","DOIUrl":"10.1016/j.amepre.2024.10.022","url":null,"abstract":"","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":"68 2","pages":"Pages 425-427"},"PeriodicalIF":4.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143147393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Incentivizing Tobacco Helpline Engagement in Persistent Poverty Counties: A Randomized Trial","authors":"Darla E. Kendzor PhD ,&nbsp;Morgan Davie BS ,&nbsp;Meng Chen PhD ,&nbsp;Jonathan Hart PhD ,&nbsp;Summer G. Frank-Pearce PhD ,&nbsp;Mark P. Doescher MD ,&nbsp;Adam C. Alexander PhD ,&nbsp;Michael S. Businelle PhD ,&nbsp;Motolani E. Ogunsanya DPh, PhD ,&nbsp;Munjireen S. Sifat PhD ,&nbsp;Laili Kharazi Boozary PhD","doi":"10.1016/j.amepre.2024.10.014","DOIUrl":"10.1016/j.amepre.2024.10.014","url":null,"abstract":"<div><h3>Introduction</h3><div>Persistent poverty counties (PPCs) are U.S. counties where ≥20% of residents have lived in poverty for ≥30 years. Cancer mortality rates in PPCs are exceptionally high due, in part, to elevated smoking rates.</div></div><div><h3>Study Design</h3><div>The study used a parallel 2-group randomized controlled trial design.</div></div><div><h3>Setting/participants</h3><div>Participants were Oklahoma Tobacco Helpline (OTH) callers from PPCs who smoked daily (<em>N</em>=165). Data were collected in 2022–2023.</div></div><div><h3>Intervention</h3><div>Participants were randomized to received OTH treatment (coaching calls plus nicotine replacement therapy [NRT]) or OTH treatment + financial incentives (OTH+FI) for completing coaching calls.</div></div><div><h3>Main Outcome Measures</h3><div>Outcome measures included the number of coaching calls completed, call-contingent incentives earned, past 7-day self-reported abstinence rates, and study retention at 8- and 12-weeks post-enrollment.</div></div><div><h3>Results</h3><div>Participants (N=165) were predominantly female (63.6%), 24.2% were racially/ethnically minoritized (18.2% single- or multi-race American Indian), and they smoked an average of 21.01 (SD=11.67) cigarettes per day. Adjusted analyses indicated that participants assigned to OTH+FI were significantly more likely than those assigned to OTH to report past 7-day abstinence at the 8-week (AOR=2.28; 95% CI=1.18, 4.48) and 12-week (AOR=2.00; 95% CI=1.03, 3.96) follow-ups when missing outcomes were considered smoking. Participants assigned to OTH+FI were more likely to complete ≥3 coaching calls (AOR=3.64; 95% CI=1.84, 7.43), and they completed more total calls (aRR=1.53; 95% CI,=1.24, 1.90) than those assigned to OTH. The number of coaching calls completed significantly mediated the relationship between treatment group assignment and abstinence at the 8- and 12-week follow-ups. Overall, study retention was &gt;83% at the 8- and 12-week follow-ups and did not differ between groups. Statistical analyses were conducted in 2024.</div></div><div><h3>Conclusions</h3><div>Findings support the feasibility and efficacy of offering small FI for completing OTH coaching calls to increase treatment engagement and smoking cessation in PPCs.</div></div>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":"68 2","pages":"Pages 336-347"},"PeriodicalIF":4.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142548762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Letter to the Editor in Response to “Psychedelic Use by Sexual Minority Adults in the United States, 2022”","authors":"Nicholas A. Carlisle JD,&nbsp;Melissa Bradley MPH,&nbsp;Peter S. Hendricks PhD,&nbsp;Sarah MacCarthy ScD","doi":"10.1016/j.amepre.2024.09.018","DOIUrl":"10.1016/j.amepre.2024.09.018","url":null,"abstract":"","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":"68 2","pages":"Pages 422-424"},"PeriodicalIF":4.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143029744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}